New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, November 13, 2026

Back to the front page

The Spy Who Shagged The Market

Nvidia’s leadership scandal puts its AI-market role under scrutiny, with comparisons to AIG’s pre-GFC liquidity influence.

AIG $43B
WHAT ARE WE DOING? “Contrarians At The Gate” 2 clicks

From X

@ActAccordingly

PAA Research on X

Not a surprise, but still encouraging. The Zelda remake from $NTDOY has a 96 right now on metacritic. It comes out today. No one seems to talk about 7974/$NTDOY because there's no Mario title this year, but putting out a remake of arguably the best video game ever made and then matching its excellence in front of a major motion picture release seems like it's good for revenue, earnings, and cash flow. I don't think investors understand the #zelda fan base. or maybe #nintendo in its entirety. @firstadopter
@aleabitoreddit

Serenity on X

Little rant, but to show you how rampant deleveraging has become: - $CIFR is worth 44% LESS than when they announced their initial $GOOGL / $AMZN colo deals. - $AAOI is now ~ the same price BEFORE they secured major hyperscaler orders, raised $1.6B for capacity expansion and gave their suprising initial -> $378M+ projection -> ~$471M revenue forecast. - $ESMT ($2B MC) is the perfect example representing the memory sector. B-BUT AI NAMES ARE NOT PROFITABLE??? Q3 Earnings: $526.2M gross profit, $330M net income. To give you a comparison of what that looks like, the net income of $CRWD ($251B MC) was literally $5.3M. $NOW ($113B MC) was $277M. $TSLA ($1.5T) was $787M. Different industries/durability, but if we care about what's actually hitting the balance sheet: ESMT is sitting on ~$937M in net assets ($740M net cash, $278M inventory, etc), so EV goes down to $1.2B ish. Annualized P/E: 1.6x... People keep saying "Peak Earnings", "Cyclical", "no moat" but who in the world would want to build an old ass DDR2 line + fab and qualify it? From ESMT commentary, we'll likely see ASP hikes Q4 to make up for potential consumer demand dropping. And further supply tightening with Samsung/Micron discontinuing DDR2/DDR3 lines. Winbond was leaving DDR2 lines to pursue higher end memory. People keep saying China, but even Gigadevice was leaving DDR3 to pursue higher end memory. "DDR3's share of our DRAM revenue will continue to decline until we eventually stop selling DDR3 products."Nanya discontinued DDR2 lines few days ago. This is while majority of ESMT revenue comes from DDR2/DDR3. In ~3 quarters of constant earnings, ESMT would have more assets than their entire MC. Who is going to stop buying $40 DLink cameras if their $3 memory cost goes to $3.5? $MU / Samsung / $SKHY / $SNDK share similar parallels where durability is contractually enforced via take/pay LTAs with price floors. But markets are pretending that it just won't happen, despite Samsung already being the most profitable company in the world. Markets should care about how much FCF is actually hitting the balance sheets, but are just indiscriminately selling off everything now. But continue rotating capital into 47x P/E companies like Walmart or 180x forward P/E names like $CRWD.

Investor Letters

All letters

QXO Inc Earnings Update: Q3 2026

QXO's Q3 sales rose 79% to $4.9 billion after TopBuild and Kodiak acquisitions, while acquisition debt lifted interest expense to $163…

QXO $13B
SixSigmaCapital: Navigating the Financial Markets 2 clicks

Cerrado Gold: Research Note

Cerrado Gold will acquire Argentina’s Manantial Espejo mine from Pan American Silver for $20 million and targets a 2027 restart funded by…

PAAS $16B
Atrium Research - Equity Research 1 click

IEH Corporation: Research Note

IEH Corporation posted Q2 revenue growth of 51% to $10.7 million and a record $56 million backlog, led by defense and medical demand.

IEHC $78M
Atrium Research - Equity Research 1 click

Qure Anniversary Update

UniQure’s Huntington’s disease BLA has a May 1, 2027 priority-review date, with an FDA advisory committee expected in late first quarter.

QURE $1.7B
Triple S Special Situations Investing 2 clicks

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

YouTube 4

Blogs 15

Seeking Alpha 88 of 290

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

376 firms

Sectors

Ordered by how often our editor reaches for them.